Latest News

TripTrends: Interest for travel to Chinese mainland bounce back since the country resumed foreign visa applications

SINGAPORE, April 18, 2023 /PRNewswire/ -- In our TripTrends series, we share the data and trends defining the global travel revival and examine the latest Trip.com data to identify the patterns emerging as travel rebounds around the world. Here, we focus on the recovery of inbound travel to Chin...

2023-04-18 09:00 3203

Global media brand Family Traveller announces Sentosa Singapore as official launch partner in Asia

SINGAPORE, April 18, 2023 /PRNewswire/ -- Family Traveller, a fast-growing global media brand, today announced the arrival of itsAsia expansion, Family Traveller Asia . Initially targeting families inSingapore, Hong Kong SAR, Malaysia, South Korea, and the Phili...

2023-04-18 09:00 3130

Hong Kong SMEs' cyber awareness declines despite rise in cyberattacks, QBE survey shows

HONG KONG, April 18, 2023 /PRNewswire/ -- Small to medium-sized enterprises (SMEs) inHong Kong are continuing to invest in digital technologies but have become less aware of cyber threats. According to research conducted at end of 2022 and released by QBE today, Hong Kong SMEs' cyber risk awarene...

2023-04-18 09:00 2908

SGK expands APAC network and opens its tenth office in Seoul

SGK continues its growth trajectory in the APAC region to shape the future of brand and consumer connection, with the opening of aSeoul office. SEOUL, South Korea, April 18, 2023 /PRNewswire/ -- SGK, a brand experience and packaging agency with over 30 years of heritage in APAC, is expanding its ...

2023-04-18 08:25 3987

USANA Malaysia Donates MYR 40,000 to Local Flood Relief

Donation in partnership with Suriana Welfare Society Malaysia KUALA LUMPUR, Malaysia, April 18, 2023 /PRNewswire/ -- Heavy flooding in Johor has led USANA Malaysia to donateMYR 40,000 in relief funds for those affected by this natural disaster. Beyond this donation, the company and its Associates...

2023-04-18 08:24 2986

Innovent Announces Updated Data of Phase 1 Clinical Trial for IBI351 (KRAS[G12C] Inhibitor) as Monotherapy for Solid Tumors at the AACR Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, April 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmolog...

2023-04-18 08:00 4305

Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease

PRINCETON, N.J., April 18, 2023 /PRNewswire/ -- EMJ Nephrology interviewed two World-renowned experts in nephrology and cardiology,George Bakris and Faiez Zannad, regarding the challenges of treating uncontrolled hypertension (uHTN) in patients with advanced chronic kidney disease (CKD), a large ...

2023-04-18 08:00 3435

Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, April 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...

2023-04-18 08:00 4182

Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, April 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...

2023-04-18 08:00 3221

Nintex transition plan announced following workflow retirement in Microsoft 365

MELBOURNE, Australia, April 18, 2023 /PRNewswire/ -- Nintex, the global standard for process intelligence and automation, today announced a transition plan for Nintex Workflow for Office 365 customers following Microsoft's decision to retire the existing Microsoft SharePoint 2013 workflow engine ...

2023-04-18 07:07 2517

PRA Group Appoints Experienced Leader Owen James as Global Investments Officer

James brings 30 years of industry experience, with the most recent 10 years at PRA Group. NORFOLK, Va., April 18, 2023 /PRNewswire/ -- PRA Group, Inc. (NASDAQ: PRAA) (the "Company), a global leader in acquiring and collecting nonperforming loans, has announced the appointment ofOwen James as glo...

2023-04-18 06:33 4502

JELD-WEN Announces Sale of Australasia Business to Platinum Equity for AU$688 Million

CHARLOTTE, N.C., April 18, 2023 /PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE: JELD), a leading global manufacturer of building products, today announced that it has completed its comprehensive review of strategic alternatives for its Australasia business and has entered into a definitive sale agr...

2023-04-18 05:30 4328

Top KingWin Ltd Announces Pricing of Initial Public Offering

GUANGZHOU, China, April 17, 2023 /PRNewswire/ -- Top KingWin Ltd ("Top KingWin" or the "Company") (Nasdaq: TCJH), a provider of capital market related education and support services, as well as advisory and transaction services in China, today announced the pricing of its initial public offering o...

2023-04-18 05:19 2836

Nintex transition plan announced following workflow retirement in Microsoft 365

AUCKLAND, New Zealand, April 18, 2023 /PRNewswire/ -- Nintex, the global standard for process intelligence and automation, today announced a transition plan for Nintex Workflow for Office 365 customers following Microsoft's decision to retire the existing Microsoft SharePoint 2013 workflow engine...

2023-04-18 05:07 2399

Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting

Promising anti-tumor activity reported for C-CAR031, a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca SHANGHAI, April 18, 2023 /PRNewswire/ -- Shanghai Cellular Biopharmaceutical Group Ltd. (the Company, or Shanghai Cellular Bio), a company engaged in the drug development...

2023-04-18 04:15 2826

Ericsson announces CFO transition

STOCKHOLM, April 18, 2023 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announced thatCarl Mellander, the Company's Chief Financial Officer, will step down at the end of the first quarter 2024. Mr. Mellander has been with Ericsson for over 25 years and has been a member of its Executive Team sinc...

2023-04-18 03:16 3152

Royal Commission for AlUla (RCU) partners with luxury hotel operator GHM to develop The Chedi Hegra within the Hegra UNESCO World Heritage Site

* The luxury boutique hotel will open by Q4 2023 with 35 guest rooms * RCU names GHM to operate the hotel under The Chedi brand * RCU is carefully uplifting several existing heritage buildings, including an old railway station, Hegra Fort, and surrounding structures, restoring them to their ...

2023-04-18 03:14 3978

NWTN Signs MOU with Al Kalid Auto L.L.C for the Sales of the Rabdan ONE in Kuwait

DUBAI, UAE, April 17, 2023 /PRNewswire/ -- NWTN Inc. (Nasdaq: NWTN), an eco-conscious mobility technology company bringing passenger-centric green premium mobility solutions to the world ("NWTN"), today announced that it signed a memorandum of understanding ("MOU") with Al Kalid Auto L.L.C. ("Al ...

2023-04-18 02:25 4507

Promising Efficacy of AT101 CAR-T for Blood Cancer

SEOUL, South Korea, April 17, 2023 /PRNewswire/ -- AbClon, a South Korean biotech firm, presented non-clinical and phase 1 interim results of its AT101 novel CAR-T therapy at the annual 2023 AACR conference. AT101 targets the CD19 protein for treatment of blood cancer. AT101 demonstrated superio...

2023-04-18 02:00 2398

EXCHANGE OFFER DECLARED UNCONDITIONAL

KAISERAUGST, Switzerland, HEERLEN, Netherlands and GENEVA, April 18, 2023 /PRNewswire/ -- THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY,THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATIO...

2023-04-18 01:51 2808